Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Regulator & HTA Bodies Prepare The Ground For New Collaborations

Executive Summary

The European Medicines Agency and EU national health technology assessment agencies have agreed a joint work plan to prepare for implementation of the new HTA regulations, including joint clinical assessments.

You may also be interested in...



The Implications Of The New EU HTA Regulation For Companies

Legal and industry expert Alexander Natz sets out key questions and answers to help companies prepare for new EU regulations on health technology assessments, one of the biggest developments to affect the pharmaceutical industry in over a decade.

New EU HTA Consortium Prepares To Launch

Two new groups have been formed in preparation for the application of the EU regulation on health technology assessment cooperation.

Scotland Okays Funding For Keytruda and Opdivo For Esophageal Cancer, Among Other Drugs

Immunotherapies for esophageal cancer from BMS and MSD are among the medicines that Scotland’s health technology appraisal body has recommended for use on the National Health system.

Topics

UsernamePublicRestriction

Register

PS146042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel